Fondazione Intergruppo Italiano Linfomi Onlus
- Research works
- 41 ▲ 18% vs 2013–17
- Citations
- 309 7.6 per fractional work
- Top-10% rate
- 23.8% record average 16.5%
- Open access
- 32% world 28%
Not ranked overall: Fondazione Intergruppo Italiano Linfomi Onlus is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
Which keywords describe research at Fondazione Intergruppo Italiano Linfomi Onlus?
By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Lymphoma, PET Imaging, Classification, Molecular Profiling, Prognostic Factors, Therapeutic Targets and Chronic Lymphocytic Leukemia.
- EGFR Mutations
- CAR T Cells
- Therapeutic Antibodies
- Kaposi's Sarcoma
- Glycosylation
- Family Perspectives
- End-of-Life
- Advance Care Planning
- Ethical Considerations
- Treatment
- Methotrexate
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Prognostic Scoring System
- Quality of Life
- Chemotherapy
- Chronic Lymphocytic Leukemia
- Prognostic Factors
- Classification
- Lymphoma
- Rituximab
- PET Imaging
- Molecular Profiling
- Therapeutic Targets
- Genomic Aberrations
- Immunotherapy
- Radiotherapy
- Minimal Residual Disease
- Cancer Incidence
- Clinical Trials
- Primary CNS Lymphoma
- Palliative Care
- Targeted Therapy
- Cancer Immunotherapy
- Epstein-Barr Virus
- Fc Receptors
- Immunosuppression
- Leukemia
- ALK Inhibitors
- Chimeric Antigen Receptor
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Rituximab14▲ 211×2 topics
- Lymphoma11▲ 182×3 topics
- PET Imaging10▲ 115×3 topics
- Classification10▲ 67×1 topic
- Molecular Profiling10▲ 205×1 topic
- Prognostic Factors7▲ 36×6 topics
- Therapeutic Targets4▲ 41×2 topics
- Chronic Lymphocytic Leukemia4▲ 192×1 topic
- Genomic Aberrations4▲ 192×1 topic
- Chemotherapy3▲ 9.3×12 topics
- Immunotherapy2▲ 7.7×8 topics
- Quality of Life2▲ 3.6×15 topics
- Radiotherapy2▲ 13×6 topics
- Prognostic Scoring System2▲ 122×2 topics
- Minimal Residual Disease2▲ 64×2 topics
- Acute Lymphoblastic Leukemia2▲ 107×1 topic
- Cancer Incidence2▲ 27×4 topics
- Childhood Cancer2▲ 107×1 topic
- Clinical Trials2▲ 6.2×6 topics
- Methotrexate2▲ 246×1 topic
- Primary CNS Lymphoma2▲ 246×1 topic
- Treatment2▲ 2.8×8 topics
- Palliative Care1▲ 19×3 topics
- Ethical Considerations1▲ 8.8×2 topics
- Targeted Therapy1▲ 14×3 topics
- Advance Care Planning1▲ 48×1 topic
- Cancer Immunotherapy1▲ 19×2 topics
- End-of-Life1▲ 34×2 topics
- Epstein-Barr Virus1▲ 87×1 topic
- Family Perspectives1▲ 48×1 topic
- Fc Receptors1▲ 26×1 topic
- Glycosylation1▲ 12×2 topics
- Immunosuppression1▲ 24×2 topics
- Kaposi's Sarcoma1▲ 87×1 topic
- Leukemia1▲ 43×2 topics
- Therapeutic Antibodies1▲ 20×1 topic
- ALK Inhibitors1▲ 46×1 topic
- CAR T Cells1▲ 59×1 topic
- Chimeric Antigen Receptor1▲ 59×1 topic
- EGFR Mutations1▲ 46×1 topic
Which research topics does Fondazione Intergruppo Italiano Linfomi Onlus publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Big Data and Business Intelligence, Chronic Lymphocytic Leukemia Research and Cytokine Signaling Pathways and Interactions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 2 Big Data and Business Intelligence Management Information Systems 0 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
- 5 Bone health and osteoporosis research Orthopedics and Sports Medicine 0 works
- 6 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
- 7 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
- 8 Vitamin D Research Studies Pathology and Forensic Medicine 0 works
- 9 Genetic Syndromes and Imprinting Genetics 0 works
- 10 Parathyroid Disorders and Treatments Nephrology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fondazione Intergruppo Italiano Linfomi Onlus's research output changed?
Output in 2018–2022 was 18% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alessandria
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo
- Istituto Tecnico Industriale Alessandro Volta
- Conservatorio Antonio Vivaldi
- Italian Foundation of Myelodysplastic Syndromes
- Procoat
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.